Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells

American Journal of Physiology - Renal Physiology

Volumn 283, Issue 5 52-5, 2002, Pages

  Alvarez, Violeta ^a   Quiroz, Yasmir ^a   Nava, Mayerly ^a   Pons, Héctor ^a   Rodríguez Iturbe, Bernardo ^a  

^a NONE   (Venezuela)

Author keywords

Interstitial nephritis; Oxidative stress

Indexed keywords

ANGIOTENSIN; MALONALDEHYDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SUPEROXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; IMMUNOCOMPETENT CELL; INFLAMMATORY INFILTRATE; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; LYMPHOCYTIC INFILTRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RAT; RENOVASCULAR HYPERTENSION; RISK FACTOR; SALT INTAKE;

EID: 0036839551     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00199.2002     Document Type: Article

References (55)

1. Allison AC and Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47: 85-118, 2000.
2. Berry C, Brosnan MJ, Fennell J, Hamilton CA, and Dominiczak AF. Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens 10: 247-255, 2001.
3. Beutler E, Duron O, and Mikus B. Improved method for the determination of blood glutathione. J Lab Clin Med 16: 882-888, 1963.
4. Blaheta RA, Leckel K, Wittig B, Zenker D, Oppermann E, Harder S, Scholz M, Weber S, Schuldes H, Encke A, and Markus BH. Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil. Transpl Immunol 6: 251-256, 1998.
5. Briggs RT, Robinson JM, Karnovsky ML, and Karnovsky MJ. Superoxide production by polymorphonuclear leukocytes. A cytochemical approach. Histochemistry 84: 371-378, 1986.
6. Burton C and Harris KPG. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 27: 765- 775, 1996.
7. Davies DJ, Brewer DB, and Hardwicke J. Urinary proteins and glomerular morphometry in protein overload proteinuria. Lab Invest 38: 232-243, 1978.
8. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 135: 719-731, 1989.
9. Eddy AA. Role of cellular infiltrates in response to proteinuria. Am J Kidney Dis 37, Suppl 2: S25-S29, 2001.
10. Eddy AA and Giachelli CM. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47: 1546-1557, 1995.
11. Franco M, Tapia E, Santamaría J, Zafra I, García-Torres R, Gordon K, Pons H, Rodríguez-Iturbe B, Johnson RJ, and Herrera-Acosta J. Renal cortical vasoconstriction contributes to the development of salt-sensitive hypertension after angiotensin II exposure. J Am Soc Nephrol 12: 2263-2271, 2001.
12. Fujihara CK, Avancini DA, Zatz R, and Noronha IL. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 54: 1510-1519, 1998.
13. Gómez-Garre D, Largo R, Tejera N, Fortes J, Manzarbeitia F, and Egido J. Activation of NF-κB in tubular epithelial cells of rats with intense proteinuria. Role of angiotensin II and endothelin-1. Hypertension 37: 1171-1178, 2001.
14. Hauser IA, Renders L, Radeke HH, Sterzel RB, and Goppelt-Struebe M. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant 14: 58-63, 1999.
15. Johnson RJ, Herrera-Acosta J, Schreiner G, and Rodríguez-Iturbe B. Subtle acquired renal injury as mechanism of salt-sensitive hypertension. N Engl J Med 346: 913-923, 2002.
16. Johnson RJ and Schreiner G. Hypothesis: Is essential hypertension an acquired tubulointerstitial renal disease? Kidney Int 52: 1169-1179, 1997.
17. Kees-Folts D, Sadow JL, and Schreiner GF. Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 45: 1697-1709, 1994.
18. Largo R, Gómez-Garre D, Soto K, Marrón B, Blanco J, Gazapo RM, Plaza JJ, and Egido J. Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 33: 732-739, 1999.
19. Lawrence GM and Brewer DB. Effect of strain and sex on the induction of hyperalbinaemic proteinuria in the rat. Clin Sci (Colch) 61: 751-756, 1981.
20. Lemley KV. Glomerular size selectivity during protein overload in the rat. Am J Physiol Renal Fluid Electrolyte Physiol 264: F1046-F1051, 1993.
21. Lippman RW. Mechanism of proteinuria: Effect of parenteral bovine albumin injections on hemoglobin excretion in rats. Am J Physiol 154: 532-536, 1948.
22. Marks MI and Drummond KN. Nephropathy and persistent proteinuria after albumin adminstration in the rat. Lab Invest 23: 416-420, 1970.
23. 2 through a PCK-dependent pathway. J Am Soc Nephrol 13: 1179-1189, 2002.
24. Muckerheide A, Apple RJ, Pesce AJ, and Michael JG. Cationization of protein antigens. I. Alteration of immunogenic properties. J Immunol 138: 833-837, 1987.
25. Nava M, Romero F, Quiroz Y, Parra G, Bonet L, and Rodríguez-Iturbe B. Melatonin attenuates acute renal failure and oxidative stress induced by mercuric chloride in rats. Am J Physiol Renal Physiol 279: F910-F918, 2000.
26. Nishiyama A, Seth DM, and Navar LG. Renal interstitial fluid concentration of angiotensins I and II in anesthetized rats. Hypertension 39: 129-134, 2002.
27. Ohkawa H, Ohishi N, and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Ann Biochem 95: 351-359, 1979.
28. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, and Seifter JL. Blood pressure control, proteinuria and the progression of renal disease. Ann Intern Med 123: 754-762, 1995.
29. Pichler R, Franceschini N, Young BA, Hugo C, Andoh TF, Burdman EA, Shankland S, Alpers CE, Bennet WM, Couser WG, and Johnson RJ. Pathogenesis of cyclosporine nephropathy: Roles for angiotensin II and osteopontin. J Am Soc Nephrol 6: 1186-1196, 1995.
30. Quiroz Y, Pons H, Gordon KL, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ, and Rodríguez-Iturbe B. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 28: F38-F47, 2001.
31. Raab M, Daxecker H, Karimi A, Markovic S, Cichna M, Markl P, and Muller MM. In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells. Clin Chim Acta 310: 89-98, 2001.
32. Ralj L, Azar S, and Keane W. Mesangial immune injury hypertension and progressive damage in Dahl rats. Kidney 26: 137-143, 1984.
33. Remuzzi G. A unifying hypothesis for renal scarring linking protein trafficking to different mediators of injury. Nephrol Dial Transplant 15, Suppl 6: 58-60, 2001.
34. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456, 1998.
35. Remuzzi G, Zoja C, Gagliardini E, Corna D, Abate M, and Benigni A. Combining antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals. J Am Soc Nephrol 10: 1542-1549, 1999.
36. Rodríguez-Iturbe B, Pons H, Herrera-Acosta J, and Johnson RJ. The role of immunocompetent cells in nonimmune renal disease. Kidney Int 59: 1626-1640, 2001.
37. Rodríguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincón J, Chávez M, Parra G, Hererra-Acosta J, Gómez-Garre D, Largo R, Egido J, and Johnson RJ. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 59: 2222-2232, 2001.
38. Rodríguez-Iturbe B, Quiroz Y, Herrea-Acosta J, Johnson RJ, and Pons HA. The role of immune cells infiltrating the kidney in the pathogenesis of salt-sensitive hypertension. J Hypertens 20, Suppl 3: S9-S14, 2002.
39. Rodríguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chávez M, Herrea-Acosta J, Johnson RJ, and Pons H. Reduction of renal immune infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 282: F191-F201, 2002.
40. Romero JC and Reckelhoff JF. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 34: 943-949, 1999.
41. Romero F, Rodríguez-Iturbe B, Parra G, González L, Herrera-Acosta J, and Tapia E. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in the rat. Kidney Int 55: 945-955, 1999.
42. Sen CK and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 10: 709-720, 1996.
43. Schreck R, Albermann K, and Baeuerle PA. Nuclear factor κB: An oxidative stress-responsive transcription factor of eukaryiotic cells. Free Rad Res Commun 17: 2221-2237, 1992.
44. Schreck R, Rieber P, and Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
45. Schnackenberg CG. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 282: R335-R342, 2002.
46. Thomas ME, Brunskill NJ, Harris KPG, Bailey E, Pringle JH, Furness PN, and Walls J. Proteinuria induces tubular cell turnover: A potential mechanism for tubular atrophy. Kidney Int 55: 890-898, 1999.
47. Vaziri ND, Ni Z, and Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31: 1248-1254, 1998.
48. Vaziri ND, Zhemin N, Oveisi F, and Trnavsky-Hobbs DL. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 2000, 36: 957-964, 2000.
49. Walls J. Relationship between proteinuria and progressive renal disease. Am J Kidney Dis 37, Suppl 2: S13-S16, 2001.
50. Wang Y, Chen J, Chen L, Tay YC, Rangan GK, and Harris DCH. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 8: 1537-1545, 1997.
51. Wang Y, Rangan GK, Tay YC, and Harris DCH. Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kB I proximal tubule cells. J Am Soc Nephrol 10: 1204-1213, 1999.
52. Weening JJ, van Guldener C, Daha MR, Klar NJ, van der Wal A, and Prins FA. The pathophysiology of protein overload proteinuria. Am J Pathol 129: 64-73, 1987.
53. Wilcox CS. Reactive oxygen species: Roles in blood pressure and kidney function. Curr Hypertens Rep 4: 160-166, 2002.
54. Wilcox CS and Welch WJ. Oxidative stress: Cause or consequence of hypertension. Exp Biol Med 226: 619-620, 2001.
55. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G. Protein overload stimulated RANTES production by proximal tubular cells depending on NF-κB activation. Kidney Int 53: 1608-1615,1998.